Ultrasound in Medicine and Biology
Volume 32, Issue 9 , Pages 1369-1375 , September 2006

The safety of Sonovue® in abdominal applications: Retrospective analysis of 23188 investigations

  • Fabio Piscaglia

      Affiliations

    • Corresponding Author InformationAddress correspondence to: Fabio Piscaglia, Div. of Internal Medicine, Via Albertoni 15, 40138 Bologna, Italy.
    • ,
  • Luigi Bolondi
    • ,
  • Italian Society for Ultrasound in Medicine and Biology (SIUMB) Study Group on Ultrasound Contrast Agents1

      Affiliations

    • L. Aiani, M. Luigi Angeli, V. Arienti, L. Barozzi, R. Basilico, M. Bertolotto, E. Biasini, P. Busilacchi, F. Calliada,* M. Caremani, E. Caturelli, N. Celli, A. Colecchia, L. Cova, M. Assunta Cova, L. Crocetti, I. de Sio, F. Drudi, G. Ferraioli, C. Filice, F. Fornari, S. Gaiani, F. Giangregorio, A. Giorgio, T. Ierace, R. Lencioni, T. Livraghi, F. Magnolfi, A. Martegani, F. Meloni, G. Menozzi, G. Pelosi, M. Pompili, L. Riccardi, P. Ricci, L. Rubaltelli, D. Sacerdoti, G. Serafini, C. Serra, L. Solbiati, D. Tacconi, M. Valentino, G. Vidili and F. Vitali

Received 28 February 2006 ,Revised 17 May 2006 ,Accepted 23 May 2006.

References 

  1. Albrecht T , Blomley M , Bolondi L , et al.   Guidelines for the use of contrast agents in ultrasound . Ultraschall in Med . 2004;25:249–256
  2. Ansell G , Tweedie MC , West CR , Evans P , Couch L . The current status of reactions to intravenous contrast media . Invest Radiol . 1980;15(Suppl. 6):S32–S39
  3. Ansell G . An epidemiologic report on adverse reactions in urography: ionic and nonionic media . Diagnostic Imaging . 1987;(Suppl.):6–10
  4. Bartolotta T , Midiri M , Quaia E , et al.   Benign focal liver lesions: spectrum of findings on SonoVue-enhanced pulse-inversion ultrasonography . Eur Radiol . 2005;15:1643–1649
  5. Beyer-Encke SA , Zeitler E . Late adverse reactions to non-ionic contrast media: a cohort analytic study . Eur Radiol . 1993;3:237–241
  6. Bokor D , Chambers J , Rees P , et al.   Clinical safety of SonoVue, a new contrast agent for ultrasound imaging, in healthy volunteers and in patients with chronic obstructive pulmonary disease . Invest Radiol . 2001;36:104–109
  7. Cochran S , Bomyea K . Trends in adverse events from iodinated contrast media . Academ Radiol . 2002;9(Suppl. 1):S65–S68
  8. European Medicines Agency (EMEA). European public assessment report. Available at: http://www.emea.eu.int/humandocs/pdfs/EPAR/sonovue/005301en1.pdf. Accessed December 22, 2005a.
  9. European Medicines Agency (EMEA). Public statement on SonoVue (Sulpher Hexafluoride). New contraindication in patients with heart disease. Restriction of use in non-cardiac imaging. Available at: http://www.emea.eu.int/pdfs/human/press/pus/021204en.pdf. Accessed December 22, 2005b.
  10. European Medicines Agency (EMEA). Press release. EMEA Committee for Medical Products for Human Use. July 27–29, 2004. Available at: http://www.emea.eu.int/pdfs/human/press/pr/2155004en.pdf. Accessed December 22, 2005c.
  11. Gaiani S , Celli N , Piscaglia F , et al.   Usefulness of contrast-enhanced perfusional sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography . J Hepatol . 2004;41:421–426
  12. Hagan J . Anaplylactoid and adverse reactions to radiocontrast agents . Immunol Allergy Clin N Am . 2004;24:507–519
  13. Hohmann H , Skrok J , Puls R , Albrecht T . Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue . ROFO . 2003;175:835–843
  14. Jakobsen J , Oyen R , Thomsen H , Morcos S  Members of Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR) . Safety of ultrasound contrast agents . Eur Radiol . 2005;5:941–945
  15. Katayama H , Yamaguchi K , Kozuka T , et al.   Adverse reactions to ionic and nonionic contrast media (A report from the Japanese committee on the safety of contrast media) . Radiology . 1990;175:621–628
  16. Kirchin M , Pirovano G , Venetianer C , Spinazzi A . Safety assessment of Gadobenate dimeglumine (MultiHance): extended clinical experience from phase I studies to post-marketing surveillance . J Magn Reson Imaging . 2001;14:281–294
  17. Morel D , Schwieger I , Hohn L , et al.   Human pharmacokinetics and safety evaluation of SonoVue, a new contrast agent for ultrasound imaging . Invest Radiol . 2000;35:80–85
  18. Murphy K , Brunberg J , Cohan R . Adverse reactions to gadolinium contrast media: a review of 36 cases . AJR . 1996;167:847–849
  19. Nanda N , Wistran D , Karlsberg R , et al.   Multicenter evaluation of SonoVue for improved endocardial border delineation . Echocardiography . 2002;19:27–36
  20. Neugut A , Ghatak A , Miller R . Anaphylaxis in the United States: an investigation into its epidemiology . Arch Intern Med . 2001;161:2046–2047
  21. Palmer FJ . The RACR survey of intravenous contrast media reactions (Final report) . Australas Radiol . 1988;32:426–428
  22. Piscaglia F , Gaiani S , Tamberi S , et al.   Liver metastases from colorectal carcinoma: progression of disease in spite of loss of arterial-phase hypervascularity on contrast perfusional angiosonography (CnTI) (A case report) . J Clin Ultrasound . 2003;31:387–391
  23. Quaia E , Calliada F , Bertolotto M , et al.   Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence . Radiology . 2004;232:420–430
  24. Quaia E , Siracusano S , Bertolotto M , Monduzzi M , Mucelli R . Characterization of renal tumours with pulse inversion harmonic imaging by intermittent high mechanical index technique: initial results . Eur Radiol . 2003;13:1402–1412
  25. Schild H . Delayed allergy-like reactions in patients: monomeric and dimeric contrast media compared with plain CT . European Radiology . 1996;6(Suppl. to issue 5):9–10
  26. Schneider M , Arditi M , Barrau M , et al.   BR1: a new ultrasonographic contrast agent based on sulfur hexafluoride-filled microbubbles . Invest Radiol . 1995;30:451–457
  27. The International Collaborative Study of Severe Anaphylaxis . Risk of anaphylaxis in a hospital population in relation to the use of various drugs: an international study . Pharmacoepidemiol Drug Saf . 2003;12:195–202
  28. Thomsen HS , Bush WH . Adverse effects of contrast media (Incidence, prevention and management) . Drug Saf . 1998;19:313–324
  29. Ueda S , Mori H , Matsumoto S , et al.   True delayed adverse reactions to non-ionic contrast media: does it really exist? . Eur Radiol . 2001;11(Suppl. 1):377
  30. Wolf G , Mishkin M , Roux S , et al.   Comparison of the rates of adverse drug reactions (Ionic contrast agents, ionic contrast agents combined with steroids and non-ionic agents) . Invest Radiol . 1991;26:404–410
  31. Yasuda R , Munechika H . Delayed adverse reactions to nonionic monomeric contrast-enhanced media . Invest Radiol . 1998;33:1–5

PII: S0301-5629(06)01643-7

doi: 10.1016/j.ultrasmedbio.2006.05.031

Ultrasound in Medicine and Biology
Volume 32, Issue 9 , Pages 1369-1375 , September 2006

Article Tools